
Neutrophils are the first immune cells on site in most infections and injuries. They are released in massive numbers from the bone marrow and recruited within hours.
๐ ๐ฒ๐ฐ๐ต๐ฎ๐ป๐ถ๐๐๐ถ๐ฐย ๐ข๐๐ฒ๐ฟ๐๐ถ๐ฒ๐ย
๐๐ฆ๐ค๐ณ๐ถ๐ช๐ต๐ฎ๐ฆ๐ฏ๐ตย โ Guided by chemokines such as CXCL8/IL-8 and adhesion molecules (selectins, integrins), neutrophils exit circulation and infiltrate tissues.ย
๐๐ง๐ง๐ฆ๐ค๐ต๐ฐ๐ณย ๐ง๐ถ๐ฏ๐ค๐ต๐ช๐ฐ๐ฏ๐ดย โ Phagocytosis of pathogens.ย
Degranulation with proteases, myeloperoxidase, and ROS.ย
๐๐ฆ๐ถ๐ต๐ณ๐ฐ๐ฑ๐ฉ๐ช๐ญย ๐ฆ๐น๐ต๐ณ๐ข๐ค๐ฆ๐ญ๐ญ๐ถ๐ญ๐ข๐ณย ๐ต๐ณ๐ข๐ฑ๐ดย (๐๐๐๐ด) โ chromatin webs coated with antimicrobial proteins.ย
๐๐ฆ๐ด๐ฐ๐ญ๐ถ๐ต๐ช๐ฐ๐ฏย โ Neutrophils undergo apoptosis, then cleared by macrophages to avoid excessive tissue damage.ย
This rapid choreography explains why neutrophils are sometimes called the ยดemergency serviceยด of the immune system.
๐๐ฒ๐ฟ๐บ๐ฎ๐ปย ๐๐ผ๐ป๐๐ฟ๐ถ๐ฏ๐๐๐ถ๐ผ๐ป๐ย
Germany has played a key role in advancing neutrophil biology:ย
Arturo Zychlinsky & Volker Brinkmann (MPI Berlin) โ first described NETs in 2004, a discovery that redefined neutrophils beyond phagocytosis [1].
Michael Hรถlzel & Thomas Tรผting (Bonn/Magdeburg) โ demonstrated that neutrophils can limit T cellโbased immunotherapy via c-METโdependent mechanisms in cancer models [2].
TRR-332 Collaborative Project โ investigates how trained neutrophils may be harnessed for anti-tumor immunity [3].
Triantafyllos Chavakis (Dresden) โ showed that beta-glucan training of neutrophils promotes anti-tumor phenotypes in mice, pointing to possible therapeutic applications [4].
๐ฆ๐ฝ๐ฒ๐ฐ๐๐น๐ฎ๐๐ถ๐๐ฒย ๐๐๐ฝ๐ผ๐๐ต๐ฒ๐๐ถ๐ย
Could neutrophils become predictive biomarkers and therapeutic targets in immunotherapy? If baseline neutrophil states โ such as their โtrainingโ status, receptor expression (e.g., c-MET), or cytokine responsiveness โ were profiled, they might guide treatmentย selection.ย โฏย
๐๐๐ฒ๐ป ๐บ๐ผ๐ฟ๐ฒ ๐ณ๐๐๐๐ฟ๐ถ๐๐๐ถ๐ฐ: neutrophils could be โtrainedโ or engineered to serve as rapid-acting immunotherapy allies, providing an early push while T cells and adaptive responses are still mobilizing. Imagine combining CAR-T cells with trained neutrophils, creating a fastโslow tandem that enhances both immediacy and durability of anti-tumor responses.โฏ
Stay tuned for ๐๐ฎ๐ ๐ญ๐ฎ: ๐ ๐ผ๐ป๐ผ๐ฐ๐๐๐ฒ๐ ๐ฎ๐ป๐ฑ ๐ ๐ฎ๐ฐ๐ฟ๐ผ๐ฝ๐ต๐ฎ๐ด๐ฒ๐ – ๐ฝ๐ต๐ฎ๐ด๐ผ๐ฐ๐๐๐ผ๐๐ถ๐
๐ฅ๐ฒ๐ณ๐ฒ๐ฟ๐ฒ๐ป๐ฐ๐ฒ๐ย
1.ย Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532โ1535.ย
2.ย Finisguerraย V, Di Conza G, Di Matteo M, et al. MET isย requiredย for the recruitment of anti-tumouralย neutrophils. Nature.ย 2015;522:349โ353.ย
3.ย TRR-332 Project: Dissecting the anti-tumourย effects of trained neutrophils. neutrophils.deย
4.ย Kalafatiย L,ย Mitroulisย I,ย Verginisย P,ย Chavakisย T. Trained immunity and neutrophils in cancer. Front Immunol.ย 2020;11:590147.ย
#100DaysOfImmunology #Neutrophils #InnateImmunity #NETs #CancerImmunotherapy #TrainedImmunity #GermanScience #ScienceCommunication #MechanisticImmunology